Health utility ratings for a spectrum of alcohol-related health states

Medical Care

Volumn 43, Issue 6, 2005, Pages 541-550

  Kraemer, Kevin L ^a,b   Roberts, Mark S ^a,b,c   Horton, Nicholas J ^d   Palfai, Tibor ^e   Samet, Jeffrey H ^f   Freedner, Naomi ^f   Tibbetts, Nicole ^g   Saitz, Richard ^f,h  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c University of Pittsburgh   (United States)

^d SMITH COLLEGE   (United States)

^e BOSTON UNIVERSITY   (United States)

^f BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g DM STAT Inc   (United States)

^h BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Alcohol; Drinking; Preferences; Utilities; Utility assessment

Indexed keywords

ADULT; ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; COMMUNITY; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DEATH; DISEASE SEVERITY; DRINKING; FEMALE; HEALTH CARE UTILIZATION; HEALTH STATUS; HUMAN; MALE; MEASUREMENT; OUTCOMES RESEARCH; RISK ASSESSMENT; VISUAL ANALOG SCALE; AGED; ATTITUDE TO HEALTH; BLINDNESS; CHILD; CROSS-SECTIONAL STUDY; DRINKING BEHAVIOR; INTERVIEW; MIDDLE AGED; PAIN ASSESSMENT; PATHOPHYSIOLOGY; PRIMARY HEALTH CARE; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; QUESTIONNAIRE; SICKNESS IMPACT PROFILE; STATISTICAL MODEL; UNITED STATES; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; ALCOHOL-RELATED DISORDERS; ATTITUDE TO HEALTH; BLINDNESS; BOSTON; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH STATUS; HUMANS; INTERVIEWS; LINEAR MODELS; MALE; MIDDLE AGED; PAIN MEASUREMENT; PENNSYLVANIA; PRIMARY HEALTH CARE; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; SICKNESS IMPACT PROFILE;

EID: 20544438260     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlr.0000163644.97251.14     Document Type: Article

References (50)

1. Gold MR, Russell LB, Seigel JE, et al., eds. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press; 1996.
2. Weinstein M, Stason W. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med. 1977;13:716-721.
3. Drummond MF, O'Brien BJ, Stoddart GL, et al. Methods for the Economic Evaluation of Health Care Programmes, 2nd ed. Oxford: Oxford University Press; 1997.
4. French MT. Economic evaluation of alcohol treatment services. Recent Dev Alcohol. 2001;15:209-228.
5. French MT. The role of health economics in substance abuse research. Recent advances and future opportunities. Overview. Recent Dev Alcohol. 2001;15:201-208.
6. Harwood HJ. Updating Estimates of the Economic Costs of Alcohol Abuse in the United States: Estimates, Update Methods and Data. National Institute of Alcohol Abuse and Alcoholism; 2000.
7. Single E, Robson L, Xie X, et al. The Costs of Substance Abuse in Canada. Ottawa, Ontario, Canada: Canadian Center on Substance Abuse; 1996.
8. Collins D, Lapsley H. The Social Costs of Drug Abuse in Australia in 1988 and 1992, monograph no. 30. Canberra: Commonwealth Department of Human Services and Health, Australian Government Publishing Service; 1996.
9. Glennie JL, Torrance GW, Baladi JF, et al. The revised Canadian Guidelines for the Economic Evaluation of Pharmaceuticals. Pharmacoeconomics. 1999;15:459-468.
10. Torrance GW. Measurement of health state utilities for economic appraisal. J Health Econ. 1986;5:1-30.
11. Gold MR, Stevenson D, Fryback DG. HALYS and QALYS and DALYS, oh my: similarities and differences in summary measures of Population Health. Annu Rev Public Health. 2002;23:115-134.
12. Johannesson M, Jonsson B, Karlsson G. Outcome measurement in economic evaluation. Health Econ. 1996;5:279-296.
13. Single E, Collins D, Easton B, et al. Proposed International Guidelines for Estimating the Costs of Substance Abuse. Ottawa, Ontario, Canada: Canadian Center on Substance Abuse; 1995.
14. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet. 1997;349:1436-1442.
15. Murray CJ, Lopez AD. The Global Burden of Disease. Boston: Harvard School of Public Health; 1996.
16. Room R, Graham K, Rehm J, et al. Drinking and its burden in a global perspective: policy considerations and options. Eur Addict Res. 2003;9:165-175.
17. Rehm J, Room R, Monteiro M, et al. Alcohol as a risk factor for global burden of disease. Eur Addict Res. 2003;9:157-164.
18. Ezzati M, Hoorn SV, Rodgers A, et al. Estimates of global and regional potential health gains from reducing multiple major risk factors. Lancet. 2003;362:271-280.
19. Holder HD, Blose JO. The reduction of health care costs associated with alcoholism treatment: a 14-year longitudinal study. J Stud Alcohol. 1992;53:293-302.
20. Fleming MF, Mundt MP, French MT, et al. Benefit-cost analysis of brief physician advice with problem drinkers in primary care settings. Med Care. 2000;38:7-18.
21. Fleming MF, Mundt MP, French MT, et al. Brief physician advice for problem drinkers: long-term efficacy and benefit-cost analysis. Alcohol Clin Exp Res. 2002;26:36-43.
22. Wutzke SE, Shiell A, Gomel MK, et al. Cost effectiveness of brief interventions for reducing alcohol consumption. Soc Sci Med. 2001;52:863-870.
23. Miller TR, Levy DT. Cost-outcome analysis in injury prevention and control: eighty-four recent estimates for the United States. Med Care. 2000;38:562-582.
24. Tengs TO, Wallace A. One thousand health-related quality-of-life estimates. Med Care. 2000;38:583-637.
25. Salomon JA, Murray CJ. Estimating health state valuations using a multiple-method protocol. In: Murray CJ, Salomon JA, Mathers CD, et al., eds. Summary Measures of Population Health. Geneva: World Health Organization; 2002:487-499.
26. Miller TR. Databook on Nonfatal Injury: Incidence, Costs, and Consequences. Urban Institute Press; 1995.
27. Miller TR. Valuing non-fatal quality of life losses with quality-adjusted life years: the health economist's meow. Journal of Forensic Economics. 2000;13:145-168.
28. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Association; 1994.
29. Lenert LA, Michelson D, Flowers C, et al. IMPACT: an object oriented graphical environment for construction of multimedia patient interviewing software. Proc Annu Symp Comput Appl Med Care. 1995:319-323.
30. Lenert LA. The reliability and internal consistency of an Internet-capable computer program for measuring utilities. Qual Life Res. 2000;9:811-817.
31. Furlong W, Feeny D, Torrance G, et al. Guide to Design and Development of Health-State Utility Instrumentation, vol 90-9. Hamilton, Ontario: McMaster University; 1990.
32. Froberg DG, Kane RL. Methodology for measuring health-state preferences - I: measurement strategies. J Clin Epidemiol. 1989;42:345-354.
33. Froberg DG, Kane RL. Methodology for measuring health-state preferences - II: scaling methods. J Clin Epidemiol. 1989;42:459-471.
34. Katz JN, Chang LC, Sangha O, et al. Can comorbidity be measured by questionnaire rather than medical record review? Med Care. 1996;34:73-84.
35. Salyers MP, Bosworth HB, Swanson JW, et al. Reliability and validity of the SF-12 health survey among people with severe mental illness. Med Care. 2000;38:1141-1150.
36. Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001;33:337-343.
37. Johnson JA, Coons SJ, Ergo A, et al. Valuation of EuroQOL (EQ-5D) health states in an adult US sample. Pharmacoeconomics. 1998;13:421-433.
38. Woloshin S, Schwartz LM, Moncur M, et al. Assessing values for health: numeracy matters. Med Decis Making. 2001;21:382-390.
39. Saunders JB, Aasland OG, Babor TF, et al. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption - II. Addiction. 1993;88:791-804.
40. Cnaan A, Laird NM, Slasor P. Using the general linear mixed model to analyse unbalanced repeated measures and longitudinal data. Stat Med. 1997;16:2349-2380.
41. Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics. 1982;38:963-974.
42. Read JL, Quinn RJ, Berwick DM, et al. Preferences for health outcomes. Comparison of assessment methods. Med Decis Making. 1984;4:315-329.
43. Stiggelbout AM, Kiebert GM, Kievit J, et al. Utility assessment in cancer patients: adjustment of time tradeoff scores for the utility of life years and comparison with standard gamble scores. Med Decis Making. 1994;14:82-90.
44. Murray CJ, Lopez AD. Evidence-based health policy - lessons from the Global Burden of Disease Study. Science. 1996;274:740-743.
45. Murray CJ, Lopez AD. Quantifying disability: data, methods and results. Bull World Health Organ. 1994;72:481-494.
46. Bury-Maynard D. Developing a Utility Index for Substance Abuse [Dissertation]. Advanced Studies in Social Welfare, Brandeis University; 1999.
47. Torrance GW, Feeny D, Furlong W. Visual analog scales: do they have a role in the measurement of preferences for health states? Med Decis Making. 2001;21:329-334.
48. Von Neumann J, Morgenstern O. Theory of Games and Economic Behavior. Princeton, NJ: Princeton University Press; 1944.
49. Froberg DG, Kane RL. Methodology for measuring health-state preferences - III: population and context effects. J Clin Epidemiol. 1989;42:585-592.
50. Lenert L, Kaplan RM. Validity and interpretation of preference-based measures of health-related quality of life. Med Care. 2000;38(suppl):II 138-150.